Advertisement
Advertisement

ONC

ONC logo

BeOne Medicines Ltd. - ADR

297.73
USD
Sponsored
-5.10
-1.69%
Jul 10, 12:28 UTC -4
Open

ONC Earnings Reports

Positive Surprise Ratio

ONC beat 5 of 17 last estimates.

29%

Next Report

Date of Next Report
Aug 27, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q2 25 (Revenue/ EPS)
--
/
--

BeOne Medicines Ltd. - ADR earnings per share and revenue

On May 06, 2026, ONC reported earnings of 1.03 USD per share (EPS) for Q1 26, beating the estimate of 0.49 USD, resulting in a 109.94% surprise. Revenue reached 10.48 billion, compared to an expected 10.50 billion, with a -0.21% difference. The market reacted with a +5.32% price change (close before vs. close after earnings).
Looking ahead to Q2 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Cybin Inc. Common Stock
Report Date
Jun 29, 2026 For Q4 26
Estimate
-$0.91
Actual
-$1.16
Surprise
-27.08%
FAQ
For Q1 2026, BeOne Medicines Ltd. - ADR reported EPS of $1.03, beating estimates by 109.94%, and revenue of $10.48B, -0.21% below expectations.
The stock price moved up 5.32%, changed from $297.49 before the earnings release to $313.32 the day after.
The next earning report is scheduled for Aug 27, 2026.
Based on -- analysts, BeOne Medicines Ltd. - ADR is expected to report EPS of -- and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement